Gilead Sciences (GILD) Underperforms Despite A Steady Stream Of Good News - Oppenheimer

August 15, 2019 7:03 AM
Oppenheimer analyst Hartaj Singh reiterated an Outperform rating and $85.00 price target on Gilead Sciences (NASDAQ: GILD) noting that the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles